Genomatica
San Diego-based Genomatica develops and licenses biological manufacturing processes for chemical production.
Founded
2000San Diego-based Genomatica develops and licenses biological manufacturing processes for chemical production.
Founded on January 1, 2000, Genomatica is a San Diego-based biotechnology company focused on developing and licensing biological manufacturing processes for the production of intermediate and basic chemicals. Their core mission is to accelerate the world's transformation to sustainable materials by replacing fossil fuel sources with plant-based alternatives. Genomatica's notable products include their process technology for 1,4-Butanediol (BDO), which has been licensed by major companies like BASF and Novamont. The company aims to make all products responsibly sourced, traceable, and transparent.
Key figures affiliated with Genomatica include CEO Christophe Schilling, Ph.D., President John G. Gugel, and Executive Chairman Carlos A. Cabrera. One of their significant achievements is producing 5 million pounds of renewable BDO in five weeks at a DuPont Tate & Lyle plant in Tennessee. This accomplishment underscores their impact on the chemical industry by providing sustainable alternatives. Through strategic partnerships and innovative technologies, Genomatica continues to influence the market by promoting environmentally friendly manufacturing processes.
Companies similar to Genomatica include Modular Genetics, Capra Biosciences, Aemetis and Zymochem.
Genomatica was founded in 2000.
Genomatica's headquarters is located in San Diego, CA, US.
As of Aug 18, 2021, Genomatica has disclosed funding of $340.3M (USD). Undisclosed round amounts are excluded.
Genomatica has 175 employees as of Feb 5, 2024.
zymochem.com
